
320. What Ibogaine Does to a Damaged Brain - Jonathan Dickinson
The Ultimate Human with Gary Brecka
Hosted by Gary Brecka
- 1h 19m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode explores the clinical applications, history, and scientific evidence behind ibogaine therapy for conditions ranging from severe addiction and traumatic brain injury to neuropathic pain and multiple sclerosis. Host Gary Brecka and guest Jonathan Dickinson, a licensed psychologist and clinical researcher, discuss how plant-based psychedelics interact with human consciousness, reset the nervous system, and restore agency to individuals suffering from treatment-resistant conditions. They examine recent peer-reviewed studies out of Stanford and other institutions showing dramatic reductions in PTSD symptoms, restored cerebral blood flow, and even significant regression of MS lesions following supervised ibogaine protocols. The conversation provides an in-depth walkthrough of a multi-day clinical treatment process, including cardiac screening, psychological preparation, and post-treatment integration.
- Preparing psychologically for ibogaine involves defining specific questions and actively engaging with the experience rather than just setting a passive intention. 0:47
- Stanford University brain scans show that ibogaine treatment is followed by increased blood flow and electrical activity in regions affected by traumatic brain injuries. 26:38
- Clinical protocols require extensive pre-screening, including blood work, electrolyte checks, and electrocardiograms, to mitigate cardiac risks such as QT prolongation. 39:28
- The day following an ibogaine session, known as the gray day, serves as an internal processing period where acute effects subside and the mind remains quiet. 42:29
Chapters
- 0:10Ibogaine’s Therapeutic Focus: Addiction and Trauma
The hosts discuss how ibogaine targets addiction, PTSD, and trauma by restoring agency and facilitating deep internal processing.
- 1:17Podcast Intro and Host Overview
Gary Brecka introduces the episode, the growing interest in psychedelic medicine, and his anticipation of speaking with psychologist Jonathan Dickinson.
- 2:00Jonathan Dickinson’s Background and Psychedelic Journey
Dickinson shares his personal and professional path into plant‑based medicine, citing mentors and the political shift toward psychedelic research.
- 54:22Cellular Metabolism and Hormetic Stress
Explores how ibogaine affects ATP production and cellular energy, linking to hormesis and adaptive stress responses.
- 54:59Regulatory History and Current Challenges
Reviews the FDA’s past trials, litigation, and the obstacles to reintroducing ibogaine for opioid use disorder.
- 56:50Psychosomatic Feedback Loops in Pain
Discusses how mental framing of injury or illness can perpetuate chronic pain and how ibogaine may shift this narrative.
- 1:04:45Cardiac Risk Management and Veteran Advocacy
Examines strategies to mitigate QT prolongation and the influence of veteran lobbying on research funding.
- 1:05:59Clinical Priorities and Funding Opportunities
Details the $50 million grant for ibogaine research and the broader push to make it a federal priority.
- 1:08:01Pathways to U.S. Approval and Rule Changes
Outlines the regulatory hurdles, including QT guidelines and opioid tapering rules, and potential pathways to approval.
- 1:11:23Efficacy Across Conditions
Ranks ibogaine’s effectiveness from opioid withdrawal to neurodegenerative disorders, highlighting its impact on trauma and pain.
- 1:16:32Ceremonial Context and Patient Engagement
Highlights the importance of ritual, community, and patient agency in the therapeutic experience of ibogaine.
Highlights
- 8:04
Addiction as Loss of Choiceinsight
The guest explains that addiction is fundamentally the loss of choice, occurring when individuals can no longer change course despite negative feedback.
- 15:00
Bicameral Mind and Sourceinsight
Drawing on Julian Jaynes's work, the discussion examines how ibogaine induces a state resembling the bicameral mind, allowing patients to interact with a deep inner intelligence.
- 23:12
Stanford TBI Study Findingsdata
Data from Stanford University's clinical research showed massive immediate drops in PTSD, depression, and anxiety scores among military veterans following treatment.
- 30:43
Severe Neuropathic Pain Casestory
A case study of a patient with a 20-year-old nerve avulsion showed his first pain-free day after treatment, leading to extended exposure protocols that yielded lasting relief.
- 41:49
Clinical Cardiac Monitoring Protocolstrategy
In over 4,000 treatments administered with ICU-level cardiac monitoring, atropine was delivered only 15 times to address asymptomatic bradycardia early.
- 47:42
Multiple Sclerosis Lesion Reductiondata
A published case series on MS patients reported a 70 percent reduction in brain white matter lesion size alongside immediate motor function improvements.
- 1:10:36
Regulatory Hurdles for Psychedelicsdebate
The guest explains why randomized placebo-controlled trials are nearly impossible with psychedelics due to immediate blinding failures when the drug takes effect.
Quotes
“The people I know that have struggled with addiction, PTSD, very often, they don't recall the trigger. But ibogaine seems to zero in directly on it.”
Gary Brecka · 0:10 “This isn't just a drug that's gonna heal your body. You have to participate in this. It's about consciousness.”
Unnamed speaker · 0:42 “Because it's incredible, like nothing else overnight mitigates the withdrawal to that extent.”
Unnamed speaker · 8:53 “So after another month, it was even better. So there was an underlying physiological basis to what they were experiencing.”
Unnamed speaker · 27:03 “There was a 70% reduction in the size of the lesions, which is what we published about in the paper.”
Unnamed speaker · 47:42 “You know, if you have a nerve impingement, you're not going to unpinge in the nerve.”
Gary Brecka · 54:29 “I think, you know, Ibogaine fits into that realm of some form of adaptive response.”
Gary Brecka · 56:07 “The FDA had approved Phase I study, NIDA was funding it. There was a bunch of reasons why that sort of fell apart.”
Unnamed speaker · 59:06 “So if that is a big component of the treatment, how do you compare it against placebo?”
Unnamed speaker · 1:10:24
Sponsored segments
- Baja Gold Sea Salt 17:17–18:31
- Ion Gear 34:00–34:46
- Ambio Life Sciences 1:17:37–1:17:50
About this episode
Ibogaine is back in the national spotlight, but what does it actually do inside the body? Licensed psychologist Jonathan Dickinson, co-founder of Ambio Life Sciences, joins Gary Brecka to break down the Stanford research on veterans with traumatic brain injury, what brain scans showed after treatment, how ibogaine affects opioid withdrawal, and why the heart is the real risk. Plus what 4,000+ treatments have taught his team about screening, magnesium, and safety. Don’t guess, test. Click here to join Gary’s VIP Community: https://bit.ly/4ai0Xwg Get Jonathan Dickinson’s book, “Ibogaine and the Bicameral Mind”: https://bit.ly/4AnHCWt To learn more about ibogaine treatment, visit Ambio Life Sciences: https://bit.ly/4k7B1e2 Connect with Jonathan Dickinson Website: https://bit.ly/4zAf2B0 Instagram: https://bit.ly/4iHzzwf Facebook: https://bit.ly/4iye9TL TikTok: https://bit.ly/4iKVUZW LinkedIn: https://bit.ly/48a39Wx Thank you to our partners AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD AIRES: “ULTIMATE20” FOR 20% OFF: https://bit.ly/4a3Duze BAJA GOLD: “ULTIMATE10” FOR 10% OFF: https://bit.ly/3WSBqUa BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV BREW: THE ULTIMATE COFFEE: https://bit.ly/4elHM82 COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp CYMBIOTIKA: “BRECKACYM30” FOR 30% OFF: https://bit.ly/4tjyluP GENETIC METHYLATION TEST (UK ONLY): https://bit.ly/48QJJrk GENETIC TEST (USA ONLY): https://bit.ly/3Yg1Uk9 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC H2TABS: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S PEPTUAL: “TUH10” FOR 10% OFF: https://bit.ly/4mKxgcn SNOOZE: LET’S GET TO SLEEP!: https://bit.ly/4pt1T6V WHOOP: JOIN & GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW Watch the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: https://bit.ly/3RPQYX8 Podcasts: https://bit.ly/3RQftU0 Connect with Gary Brecka Instagram: https://bit.ly/3RPpnFs TikTok: https://bit.ly/4coJ8fo X: https://bit.ly/3Opc8tf Facebook: https://bit.ly/464VA1H LinkedIn: https://bit.ly/4hH7Ri2 Website: https://bit.ly/4eLDbdU Merch: https://bit.ly/4aBpOM1 Newsletter: https://bit.ly/47ejrws Ask Gary: https://bit.ly/3PEAJuG Timestamps 00:00 - Introduction: Ibogaine and plant-based medicine 03:23 - From SSRI withdrawal to ibogaine clinics 06:51 - How ibogaine eases opioid withdrawal 10:24 - Why veterans rarely relive combat 13:47 - The bicameral mind and ibogaine visions 21:14 - Stanford study on veterans with TBI 24:10 - What brain scans showed after treatment 28:22 - Ibogaine for severe neuropathic pain 33:40 - Cardiac risk and QT prolongation 36:42 - Inside the five-day ibogaine treatment 41:26 - Ibogaine and multiple sclerosis lesions 52:14 - Ibogaine, ATP and cellular energy 56:00 - Why ibogaine still isn't legal in the US 59:48 - Why Suboxone blocks ibogaine treatment 01:02:32 - The executive order and $50M grant 01:06:26 - The placebo problem in psychedelic trials 01:08:26 - Which conditions respond best 01:14:16 - Jonathan's new book and Ambio Disclaimer: This podcast is for informational purposes only and does not provide medical advice. It is not intended for diagnosing or treating any health condition. Always consult a licensed healthcare professional before making health or wellness decisions. The views and statements of guests are their own and do not necessarily reflect those of The Ultimate Human or Gary Brecka. Gary Brecka is the owner of Ultimate Human, LLC which operates The Ultimate Human podcast and promotes certain third-party products used by Gary Brecka in his personal health and wellness protocols and daily life and for which Ultimate Human LLC and / or Gary Brecka directly or indirectly holds an economic interest or receives compensation. Accordingly, statements made by Gary Brecka and others (including on The Ultimate Human podcast) may be considered promotional in nature. Learn more about your ad choices. Visit megaphone.fm/adchoices
Transcript
12,952 words · 3 speakers
Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.
Topics
- Ibogaine
- Suboxone
- FDA
- Opioid use disorder
- NIDA
- Substance
Page updated · transcript and summary are machine-generated